Professor Saad Usmani from the Levine Cancer Institute in Charlotte, North Carolina gave delegates attending the Janssen H3 medical education symposium in Melbourne an overview of the diverse strategies by which monoclonal antibodies (MAbs) are helping to tackle multiple myeloma (MM). “As our understanding of myeloma biology has expanded, we’re in a position where we ...
Monoclonal antibodies in multiple myeloma: helping us to take back control of the immune system
17 Sep 2019
Sponsored by Janssen-Cilag Pty Ltd